Jeffrey Greenwald, MD, a hospitalist at Massacusetts General Hospital with 15 years of experience in hospital medicine, discusses his view of the spectrum of endocrine disorders and how hospitalists should approach the question of when to call in an endocrine specialist.
Related Articles
![1]()
SGLT2 inhibitor use tied to fewer atrial arrhythmias
April 4, 2015
A prospective study of nearly 14,000 patients who received an implantable cardiac device suggests that SGLT2-inhibitor treatment cuts atrial arrhythmias.
![1]()
Empagliflozin a winner in challenging arena of stabilized acute HF
April 4, 2015
Early in-hospital initiation of SGLT2 inhibitors “should be considered the new standard of care” in most patients with heart failure regardless of their ejection fraction, says an expert observer.
![1]()
EMPEROR-Preserved findings confirmed in ‘true’ HFpEF patients
April 4, 2015
A landmark trial proved empagliflozin’s efficacy in HFpEF, but many patients had “moderately reduced” EFs. The findings hold up even without them.
![1]()
Opioid-induced adrenal insufficiency for the hospitalist
April 4, 2015
Opioid-induced adrenal insufficiency is an underrecognized cause of central adrenal insufficiency.
